最近的类药物作为有希望的抗菌剂的进展,以准各种微生物物种
Yi Gao1, Jingliang Cui1, Shuang Cao1
1Key Laboratory for Green Chemical Process of Ministry of Education, Wuhan Institute of Technology 206 1st Rd Optics Valley, East Lake New Technology Development District, Wuhan, Hubei, 430205, China; Hubei Key Laboratory of Novel Reactor and Green Chemical Technology, Wuhan Institute of Technology 206 1st Rd Optics Valley, East Lake New Technology Development District, Wuhan, Hubei 430205, China; Hubei Engineering Research Center for Advanced Fine Chemicals, Wuhan Institute of Technology 206 1st Rd Optics Valley, East Lake New Technology Development District, Wuhan, Hubei, 430205, China; School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology 206 1st Rd Optics Valley, East Lake New Technology Development District, Wuhan, Hubei, 430205, China.
类,合成分子,对抗药物耐药微生物表现出广泛的抗菌活性. 本次审查强调了它们的潜力和未来发展,以应对全球健康威胁.
科学领域:
- 生物化学和药物化学 医学化学
- 微生物学与传染病的研究
背景情况:
- 耐多药性微生物物种对全球健康构成重大挑战.
- 迫切需要新的抗微生物药物来对抗耐药性病原体.
- 类药物,合成类模拟剂,提供有前途的抗菌性质.
研究的目的:
- 为最近在使用类药物作为抗菌剂方面取得的进展提供全面的回顾.
- 讨论类的合成策略和抗菌机制.
- 确定抗微生物类研究的局限性和未来方向.
主要方法:
- 关于类和抗微生物活性的科学出版物的文献综述.
- 对详细介绍质合成和作用机制的研究进行分析.
- 批判性评估当前的研究缺口和未来的前景.
主要成果:
- 类体对细菌,真菌,病毒和寄生虫具有广泛的活性.
- 类药物表现出对酶降解的稳定性,选择性和易于合成.
- 最近的研究突出了各种合成方法和作用机制.
结论:
- 类是开发新抗微生物疗法的有前途的化合物类别.
- 解决目前的缺陷和研究缺口对于优化基于类的治疗至关重要.
- 对于抗击多药耐药微生物,在类设计和应用方面的进一步创新是必不可少的.
相关概念视频
Biological Methods for Microbial Control
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Gene Regulation in Microbial Communities: Quorum Sensing
Microorganisms in Medicine and Therapeutics
Antimicrobial Effectiveness
Development of Antibiotic Resistance


